Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Unemo M, Nicholas RA.

Future Microbiol. 2012 Dec;7(12):1401-22. doi: 10.2217/fmb.12.117. Review.

2.

Challenges with gonorrhea in the era of multi-drug and extensively drug resistance - are we on the right track?

Unemo M, Golparian D, Shafer WM.

Expert Rev Anti Infect Ther. 2014 Jun;12(6):653-6. doi: 10.1586/14787210.2014.906902. Epub 2014 Apr 4.

3.

Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.

Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M.

Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45. doi: 10.1128/AAC.00325-11. Epub 2011 May 16.

4.

High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.

Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P.

Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80. doi: 10.1128/AAC.05760-11. Epub 2011 Dec 12.

5.

Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.

Tapsall JW, Ndowa F, Lewis DA, Unemo M.

Expert Rev Anti Infect Ther. 2009 Sep;7(7):821-34. doi: 10.1586/eri.09.63. Review.

PMID:
19735224
6.

Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.

Lee H, Unemo M, Kim HJ, Seo Y, Lee K, Chong Y.

J Antimicrob Chemother. 2015 Sep;70(9):2536-42. doi: 10.1093/jac/dkv146. Epub 2015 Jun 17.

7.

In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?

Unemo M, Golparian D, Limnios A, Whiley D, Ohnishi M, Lahra MM, Tapsall JW.

Antimicrob Agents Chemother. 2012 Jul;56(7):3603-9. doi: 10.1128/AAC.00326-12. Epub 2012 Apr 30.

8.

The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting.

Whiley DM, Goire N, Lahra MM, Donovan B, Limnios AE, Nissen MD, Sloots TP.

J Antimicrob Chemother. 2012 Sep;67(9):2059-61. doi: 10.1093/jac/dks188. Epub 2012 May 17. Review.

PMID:
22604449
9.

Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Unemo M, Shafer WM.

Clin Microbiol Rev. 2014 Jul;27(3):587-613. doi: 10.1128/CMR.00010-14. Review.

10.

Preparing for an era of untreatable gonorrhea.

Barbee LA.

Curr Opin Infect Dis. 2014 Jun;27(3):282-7. doi: 10.1097/QCO.0000000000000058. Review.

11.

The use of cephalosporins for gonorrhea: the impending problem of resistance.

Barry PM, Klausner JD.

Expert Opin Pharmacother. 2009 Mar;10(4):555-77. doi: 10.1517/14656560902731993 . Review.

12.

Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan.

Shimuta K, Watanabe Y, Nakayama S, Morita-Ishihara T, Kuroki T, Unemo M, Ohnishi M.

BMC Infect Dis. 2015 Sep 17;15:378. doi: 10.1186/s12879-015-1110-x.

14.

Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union.

Unemo M, Ison CA, Cole M, Spiteri G, van de Laar M, Khotenashvili L.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv42-6. doi: 10.1136/sextrans-2012-050909. Review.

PMID:
24243879
15.

Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.

Mlynarczyk-Bonikowska B, Serwin AB, Golparian D, Walter de Walthoffen S, Majewski S, Koper M, Malejczyk M, Domeika M, Unemo M.

BMC Infect Dis. 2014 Feb 6;14:65. doi: 10.1186/1471-2334-14-65.

16.

Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance.

Cole MJ, Spiteri G, Jacobsson S, Pitt R, Grigorjev V, Unemo M; Euro-GASP Network..

BMC Infect Dis. 2015 Aug 11;15:321. doi: 10.1186/s12879-015-1013-x.

17.

Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):873-7.

18.

Global resistance of Neisseria gonorrhoeae: when theory becomes reality.

Lewis DA.

Curr Opin Infect Dis. 2014 Feb;27(1):62-7. doi: 10.1097/QCO.0000000000000025. Review.

PMID:
24275696
19.

Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.

Tzelepi E, Daniilidou M, Miriagou V, Siatravani E, Pavlidou E, Flemetakis A.

J Antimicrob Chemother. 2008 Sep;62(3):637-9. doi: 10.1093/jac/dkn236. Epub 2008 Jun 12. No abstract available.

PMID:
18556708
20.

Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.

Morita-Ishihara T, Unemo M, Furubayashi K, Kawahata T, Shimuta K, Nakayama S, Ohnishi M.

J Antimicrob Chemother. 2014 Aug;69(8):2086-90. doi: 10.1093/jac/dku118. Epub 2014 Apr 28.

PMID:
24777907

Supplemental Content

Support Center